SM1-71 Chemical Properties

Density 

1.333±0.06 g/cm3(Predicted)

storage temp. 

Store at -20°C

solubility 

DMSO: 2mg/mL, clear

form 

Solid

pka

13.07±0.70(Predicted)

color 

White to off-white

SM1-71 Usage And Synthesis

Uses

SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines[1][2][3].

Biological Activity

SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines[1][2][3]. SM1-71 (0.001-100 μM; 72 h) potently inhibits the proliferation of H23 and Calu-6 non-small cell lung cancer cell lines with a concentration-dependent manner[1].SM1-71 (72 h) induces potent cytotoxicity with nanomolar values for GR50 and negative GRmax values in eight of 11 cancer cell lines[2].

IC 50

LIMK1; RSK2

References

[1]. Rao S, et, al. Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome. Cell Chem Biol. 2019 Jun 20; 26(6): 818-829.e9. [2]. Rao S, et, al. A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers. J Biol Chem. 2019 May 24;294(21):8664-8673. [3]. Tan L, et, al. Structure-guided development of covalent TAK1 inhibitors. Bioorg Med Chem. 2017 Feb 1; 25(3): 838-846.

SM1-71(2088179-99-9)Related Product Information

• 6-aMino-9-benzyl-2-(2-Methoxyethoxy)-9H-purin-8-ol
• SMI-4a
• N-(4-BroMophenyl)-3,5-diMethyl-1-piperidinepropanaMide Hydrochloride
• 2-(6-amino-5-(piperazin-1-yl)pyridazin-3-yl)phenol hydrochloride
• (4-Chloro-3-nitrophenyl)(4-(2-fluorophenyl)piperazin-1-yl)Methanone
• SM 7368
• SMI-16a
• SM-276001